Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Research & Development (2020 - 2026)

Updated

Context Therapeutics (CNTX) recorded Research & Development of $5.72 million in Q3 2026, down 34.5% from $8.72 million a year earlier and down 54.4% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Research & Development (2020 - 2026) Analysis & Trends

On a TTM basis, Context Therapeutics' Research & Development came in at $37.1 million as of Sep 30, 2026, up 64.7% year-over-year; for FY2025, it was $31.86 million, up 40.3% from FY2024.

  • Annual Research & Development has increased for five straight years, with a five-year compound annual growth rate of 81.0% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $22.7 million in FY2024 (+27.7%), $17.78 million in FY2023 (+150.8%), $7.09 million in FY2022 (+86.4%) and $3.81 million in FY2021 (+131.8%).
  • The Q3 2026 figure is the lowest quarterly Research & Development since Q1 2025.
  • On a year-over-year basis, Research & Development rose in five of the last eight quarters, with growth averaging 117.3%.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 465.6% in Q2 2025, against a decline of 60.0% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $12.53 million (Q2 2026), $7.02 million (Q1 2026) and $11.84 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 322,296.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 4.25 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 4.65 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 2.57 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 4.54 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 1.61 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - 5.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.72 Mn
Jun 30, 2026 12.53 Mn
Mar 31, 2026 7.02 Mn
Dec 31, 2025 11.84 Mn
Sep 30, 2025 8.72 Mn
Jun 30, 2025 7.83 Mn
Mar 31, 2025 3.46 Mn
Dec 31, 2024 2.52 Mn
Sep 30, 2024 16.83 Mn
Jun 30, 2024 1.38 Mn
Mar 31, 2024 1.97 Mn
Dec 31, 2023 5.30 Mn
Sep 30, 2023 4.49 Mn
Jun 30, 2023 3.46 Mn
Mar 31, 2023 4.53 Mn
Dec 31, 2022 2.14 Mn
Sep 30, 2022 2.08 Mn
Jun 30, 2022 1.52 Mn
Mar 31, 2022 1.35 Mn
Dec 31, 2021 1.29 Mn
API Access

Context Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CNTX&period=max&api_key=YOUR_API_KEY